Fabry disease manifests as a hereditary lysosomal disorder resulting from GLA gene mutations causing alpha-galactosidase A enzyme deficiency. This enzymatic disruption creates toxic glycosphingolipid accumulation, notably globotriaosylceramide (Gb3), producing systematic organ deterioration across kidney, heart, and nervous system domains while severely compromising patient longevity and daily...